Description
Description
Pazokast 400
Composition: Pazopanib 400 mg
Therapeutic Class: Anti-neoplastic
Pazokast: Widely Used in Leading Healthcare Settings
Pazokast, available globally, is widely trusted and highly trusted by oncologists.
It is widely prescribed for various types of cancers.
Why Aprazer’s Pazokast?
- • It is widely demanded in global hospitals, anticancer institutes, and government healthcare settings.
- • Aprazer leads the way in affordable oncology medicines, manufacturing a vast range of anticancer drugs.
- • WHO- GMP certified, assured therapeutic efficacy and safety.
What is Pazokast?
Pazokast is a targeted therapy drug that is well tolerated and is used against varied types of kidney cancers and soft tissue cancers.
Uses of Pazokast
- • Renal cell carcinoma
- • Advanced soft tissue sarcoma
How does it work?
- • Multiple Tyrosine Kinase Inhibitors
- • It inhibits the growth factors of the cancer cell, inhibiting cancer growth and proliferation.
Common Side Effects
- • Changes in vision
- • Swelling in the body
- • Shortness of breath
- • Hair discoloration
- • Changes in taste
- • Fatigue
- • Irregular heartbeat
- • Nausea, vomiting
Serious Side Effects
- • Bleeding in urine or stool
- • Cardiac abnormalities – heart attack, stroke
- • QT prolongation
- • Neurological dysfunctions – seizures, confusion
- • Blurred vision
- • Elevated liver enzymes
- • Thromboembolism
- • Delayed wound healing
Precautions
To be used cautiously in:
- • Pre-existing liver dysfunctions
- • Hypertension and cardiovascular diseases
- • Patients with recent surgeries
- • Renal impaired functions
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to pazopanib or any excipients
- • Breastfeeding mothers
- • Pregnant women
Warning
- • To be used under medical prescription only
Safety and Monitoring Information
Regular monitoring of:
- • Liver functions
- • Blood pressure
- • Heart rhythms –ECG
- • Total blood count
- • Coagulation profile
Download Product PDF Attachment
